Emily Waltz Ambulances queue at a London hospital during a COVID-19 surge driven by the Omicron variant. Credit: Mark Thomas/Shutterstock As the Omicron variant of SARS-CoV-2 continues its global rampage, vaccine makers are pouring resources into clinical trials of COVID-19 shots tailored to the highly transmissible variant. But a raft of early animal studies suggest...
